Altered G-protein coupling of a frontal cortical low affinity [3H]8-hydroxy-N,N-dipropyl-2-aminotetralin serotonergic binding site in Alzheimer's disease

Behavioural Brain Research

Volumn 73, Issue 1-2, 1995, Pages 325-329

  Weinstein, D ^a   Magnuson, D ^b   Lee, J ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's; G protein; Serotonin; OH DPAT

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN 1A RECEPTOR;

AGED; ALZHEIMER DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AGED; ALZHEIMER DISEASE; FEMALE; GTP-BINDING PROTEINS; GUANYLYL IMIDODIPHOSPHATE; HUMANS; MALE; PREFRONTAL CORTEX; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SYNAPTIC TRANSMISSION;

EID: 13344277367     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00121-0     Document Type: Article

References (26)

1. Neurotransmitter enzyme abnormalities in senile dementia
2. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type
3. Alzheimer's diseas: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups
4. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles
5. Cholinomimetic treatment fails to improve memory disorders
6. Tacrine in Alzheimer's disease
7. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies
8. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease
9. The neuropathology of aminergic nuclei in Alzheimer's disease
10. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons
11. Evidence for neurofibrillary tangles (NFTs) in pontine 5-HT neurons in Alzheimer's disease (AD)
12. Evaluation of zimeldine in Alzheimer's disease, cognitive and biochemical measures
13. A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia
14. 3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain
15. Serotonergic control of cerebral activity and behavior models of dementia
16. 1D agonists increase hippocampal acetylcholine (ACh) efflux in conscious guinea pig
17. Diagnosis of Alzheimer's disease
18. Neuritic pathology and dementia in Alzheimer's disease
19. Identification of 5-hydroxytryptamine 1D binding sites in human brain membranes
20. Graphic method for the determination and presentation of binding parameters in a complex system
21. 1B recognition sites
22. 1A receptor
23. Preservation of 5-hydroxytryptamine 1A receptor-G-protein interactions in the cerebral cortex of patients with Alzheimer's disease
24. 7 serotonin receptor subtype
25. 7) activating cAMP formation
26. Astrocytes associated with senile plaques possess muscarinic acetylcholine receptors